Thomas Patrick Kelly - Jun 16, 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Chief Financial Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Jun 16, 2023
Transactions value $
-$23,835
Form type
4
Date filed
6/21/2023, 04:05 PM
Previous filing
Feb 17, 2023
Next filing
Oct 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$23.8K -1.66K -2.81% $14.40 57.1K Jun 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock units.